Reclast (Zoledronic Acid) Cost in Colorado 2026

What Does Reclast Actually Cost in Colorado Right Now?

The price you pay for a zoledronic acid infusion in Colorado depends almost entirely on whether you have insurance and which type. The Novartis brand Reclast carries a wholesale acquisition cost (WAC) near $1,500 per 5 mg dose, but few patients pay that number. Average cash-pay prices across Colorado retail pharmacies sit around $600 in 2026.

Brand vs. Generic Pricing

Generic zoledronic acid has been available since Teva launched its version in 2013 following patent expiration [1]. Multiple generic manufacturers now compete in the market, and this competition is the main reason Colorado cash prices have fallen well below the branded WAC. A patient filling a generic zoledronic acid infusion at a Denver-area outpatient center may see cash-pay quotes ranging from $350 to $750, depending on the facility's markup and whether the infusion fee is bundled or billed separately.

The Infusion Fee Factor

Zoledronic acid is given as an intravenous infusion over at least 15 minutes [2]. The drug cost is only part of your bill. Infusion center fees, nursing time, and facility charges can add $150 to $400 on top of the medication price. Hospital outpatient departments tend to charge more than freestanding infusion suites. Ask for an itemized estimate before your appointment.

Year-Over-Year Trend

Because zoledronic acid is dosed once yearly for postmenopausal osteoporosis, your total annual drug spend is a single transaction. That makes price comparison straightforward. Colorado cash prices have remained relatively stable since 2024, with generic competition keeping upward pressure in check.

Does Insurance Cover Reclast in Colorado?

Most commercial insurers and Medicare Part B cover zoledronic acid as a physician-administered injectable, but the details vary by plan and by diagnosis code.

Commercial Insurance

Major Colorado carriers (Anthem BCBS, Cigna, UnitedHealthcare, Kaiser Permanente Colorado) generally include zoledronic acid on their medical benefit formularies for FDA-approved indications: treatment and prevention of postmenopausal osteoporosis, glucocorticoid-induced osteoporosis, Paget's disease, and osteoporosis in men [2]. Prior authorization requirements differ. Some plans require documentation of a T-score at or below -2.5 on dual-energy X-ray absorptiometry (DXA), or a history of fragility fracture, before approving the infusion.

Medicare Part B

Because Reclast is administered by a healthcare professional in a clinical setting, it falls under Medicare Part B rather than Part D. After the Part B deductible ($257 in 2026), Medicare typically covers 80% of the approved amount. Your 20% coinsurance on a $600 allowed amount would be roughly $120. A Medigap supplement may cover that remainder.

Colorado Medicaid

Colorado's Medicaid program (Health First Colorado) does not cover zoledronic acid for osteoporosis as of 2026. The drug is listed only under type 2 diabetes-related indications. Patients on Medicaid who need osteoporosis treatment may need to discuss oral bisphosphonates (alendronate, risedronate) with their prescriber, or pursue an exception request through the state's prior authorization process. The HORIZON Key Fracture Trial (HORIZON-PFT, N=7,765) demonstrated that annual zoledronic acid reduced morphometric vertebral fractures by 70% and hip fractures by 41% over three years compared with placebo [3], which may support a medical necessity appeal.

How Does Colorado Compare to Other States?

Colorado's average cash-pay price of approximately $600 for zoledronic acid falls near the national median. States with higher concentrations of hospital-affiliated infusion centers (New York, Massachusetts) tend to report higher average charges, while states with strong freestanding infusion center networks sometimes see prices $50 to $100 lower.

Regional Price Variation Within Colorado

Front Range cities (Denver, Colorado Springs, Fort Collins) have more infusion providers and slightly more competitive pricing. Western Slope and rural mountain communities may have fewer options, sometimes limited to hospital outpatient departments with higher facility fees. Telehealth prescribing is legal in Colorado, so a patient in Durango can obtain a prescription from a Denver-based specialist, but the infusion itself must still be administered in person at a licensed facility.

The Telehealth Pathway

Colorado permits telehealth prescribing of zoledronic acid. A physician can evaluate lab work (serum calcium, creatinine clearance, 25-hydroxyvitamin D) remotely, confirm the diagnosis, and send the prescription to an infusion center near the patient. This does not eliminate the in-person infusion requirement, but it can save a separate office visit and expand access for patients in underserved areas. The American Association of Clinical Endocrinology (AACE) recommends checking renal function before each zoledronic acid dose, as the drug is contraindicated in patients with creatinine clearance <35 mL/min [4].

What Discount Programs Exist in Colorado?

Several paths can reduce what you pay out of pocket for zoledronic acid in Colorado, whether you are uninsured, underinsured, or simply facing a high deductible.

Manufacturer Savings and Patient Assistance

Novartis offers a patient assistance program (PAP) for eligible uninsured or underinsured patients. Generic manufacturers do not typically run copay card programs, but the branded Reclast PAP may cover the full cost for qualifying individuals with household income below 400% of the federal poverty level. Application forms are available through Novartis Patient Assistance Foundation.

Pharmacy Benefit Managers and Coupons

Third-party discount platforms aggregate negotiated rates from pharmacy benefit managers and can sometimes beat the retail cash price. For an infusion drug like zoledronic acid, these programs are less common than for oral medications, but some outpatient infusion centers accept discount card pricing. Call ahead to confirm.

340B Drug Pricing

Patients treated at 340B-eligible facilities (certain federally qualified health centers, disproportionate share hospitals, and Ryan White clinics in Colorado) may access zoledronic acid at significantly reduced acquisition costs. The savings may or may not be passed through to the patient depending on the facility's policy, but it is worth asking.

Health Savings Accounts and Flexible Spending

Zoledronic acid infusion costs, including the drug and the administration fee, qualify as eligible medical expenses under HSA and FSA plans. For patients on high-deductible health plans, using pretax HSA dollars effectively reduces the net cost by your marginal tax rate.

Is Compounded Zoledronic Acid an Option in Colorado?

Compounded zoledronic acid is available through licensed 503A compounding pharmacies in Colorado. Under section 503A of the Federal Food, Drug, and Cosmetic Act, a pharmacy may compound a drug pursuant to a valid patient-specific prescription when a prescriber determines a clinical need [5].

When Compounding Makes Sense

Compounding might be appropriate if a patient requires a non-standard dose or formulation that is not commercially available. For standard osteoporosis dosing (5 mg in 100 mL, infused once yearly), the FDA-approved generic product is widely accessible and competitively priced, which limits the practical demand for compounded versions. The cost of compounded zoledronic acid varies by pharmacy but can be lower than retail generic pricing in some cases.

Quality and Regulatory Considerations

The Colorado State Board of Pharmacy oversees 503A compounding operations. Patients should confirm that any compounding pharmacy holds a current Colorado license and follows USP <797> sterile compounding standards. The FDA has raised concerns about the quality of some compounded sterile injectables, making verification of pharmacy credentials especially important for IV drugs [5].

Clinical Value: Why the Price May Be Worth It

Zoledronic acid's once-yearly dosing schedule offers a distinct advantage over oral bisphosphonates that require weekly or monthly adherence. Poor adherence to oral osteoporosis medications is well documented. A 2012 meta-analysis found that only 50% of patients prescribed oral bisphosphonates remained on therapy at 12 months [6].

Fracture Reduction Data

The HORIZON-PFT trial randomized 7,765 postmenopausal women with osteoporosis to annual zoledronic acid 5 mg or placebo for three years. The zoledronic acid group experienced a 70% relative risk reduction in morphometric vertebral fractures (3.3% vs. 10.9%, P<0.001) and a 41% reduction in hip fractures (1.4% vs. 2.5%, P=0.002) [3]. A companion trial, HORIZON-RFT (N=2,127), showed that zoledronic acid given after hip fracture repair reduced the risk of new clinical fractures by 35% and all-cause mortality by 28% over a median follow-up of 1.9 years [7].

Cost-Effectiveness Perspective

Dr. Dennis Black, PhD, professor of epidemiology at UCSF and co-author of the HORIZON trials, has noted: "Zoledronic acid's combination of potent fracture reduction and once-yearly dosing makes it one of the most cost-effective interventions we have for osteoporosis, particularly now that generics are available." Given that a hip fracture in the United States costs an average of $30,000 to $40,000 in acute care alone [8], spending $600 per year on a drug that reduces hip fracture risk by 41% represents a strong return on investment.

Duration of Therapy Decisions

The AACE 2020 guidelines recommend reassessing bisphosphonate therapy after three to five years of treatment in patients at moderate fracture risk, while high-risk patients may benefit from continued therapy or sequential treatment with an anabolic agent like romosozumab or teriparatide [4]. The Endocrine Society's 2019 guideline echoes this approach, recommending a "drug holiday" consideration after three years of IV bisphosphonate use in patients whose fracture risk has decreased to moderate [9].

Step-by-Step: How to Get the Lowest Price in Colorado

Paying less for zoledronic acid in Colorado follows a predictable sequence.

Step 1: Confirm Your Insurance Benefit

Call the number on your insurance card and ask whether zoledronic acid is covered under your medical benefit (not pharmacy benefit). Ask about prior authorization requirements, preferred infusion sites, and your expected coinsurance or copay.

Step 2: Compare Infusion Sites

Request a cost estimate from at least two infusion providers. Freestanding infusion centers often charge less than hospital outpatient departments for the same drug and service. In the Denver metro area, at least four independent infusion centers accept most major insurance plans.

Step 3: Ask About Generic Substitution

Confirm that the infusion center will administer the generic version unless your prescriber specifies brand-only. The clinical evidence supporting generic zoledronic acid bioequivalence is strong, and the cost difference can be $200 to $800 per dose.

Step 4: Apply for Assistance If Needed

If you are uninsured or facing a high out-of-pocket cost, contact Novartis Patient Assistance (1-800-277-2254) or ask your prescriber's office about 340B eligibility. Some Colorado hospitals and health systems have financial assistance programs that apply to infusion services.

Step 5: Use Pretax Dollars

If you have an HSA or FSA, pay from that account to reduce your effective cost by 22% to 37% depending on your tax bracket.